All COVID-19 articles
-
NewsCOVID racism driven by more than fear of infection
Anti-Asian discrimination and violence increased during COVID, and new research has revealed one key psychological driver. Rather than being driven by a fear of infection, aggressive forms of discrimination appeared to be more strongly associated with anger.
-
NewsSweeping up dust to detect emerging viruses
Gathering dust from buildings may hold promise as a more efficient way to track viral outbreaks in indoor settings, according to a new study. After collecting nearly 30 vacuumed dust samples from different buildings, researchers simultaneously identified the presence of 54 distinct viruses.
-
-
NewsMeasuring SARS-CoV-2 diversity in wastewater improves disease surveillance
Tracking the genetic diversity of SARS-CoV-2 in wastewater, rather than just viral abundance, dramatically improves the ability to monitor and predict COVID-19 outbreaks, researchers report.
-
NewsIgG fucosylation linked to severe COVID-19 progression and traditional Chinese medicine therapy
A new study has uncovered that immunoglobulin G (IgG) fucosylation, a critical type of protein glycosylation, is closely associated with the progression of severe COVID-19, offering new insights into disease pathogenesis and potential therapeutic strategies.
-
NewsDiseases can spread between apartments via shared ventilation, study shows
Airborne diseases like measles, influenza and COVID-19 can easily spread between units in multi-family buildings via a type of bathroom ventilation system commonly used around the world, new research suggests.
-
NewsFlawed but correctable research hindered progress in infection-triggered chronic conditions
Researchers contend that studies of infection-associated chronic illnesses such as Lyme disease and COVID-19 suffer recurring problems such as the failure to prove participants have the relevant pathogen.
-
NewsStudy reveals common mutation linked to autoimmune diseases may protect people from viral infections
New research shows a “risk gene” linked to higher odds of developing autoimmune diseases such as diabetes or lupus may also provide a survival advantage fighting viral infections like coronavirus. The gene PTPN22 carries a mutation, 1858C>T (R620W), found in roughly one in 10 people in North America.
-
NewsPregnant women’s mental images are directly linked to vaccine hesitancy and uptake
When pregnant women think about vaccinations, many experience vivid mental images – such as a sick baby in hospital – that have a direct link to their opinion of the vaccine and whether they ultimately have it, new research has shown.
-
News‘Atomic snapshots’ of proofreading enzyme could lead to better COVID-19 drugs
A research team used images generated by a cryogenic electron microscope (cryo-EM) to observe the interplay between SARS-CoV-2 proofreading enzyme exoribonuclease (ExoN) and RNA incorporated with antivirals such as remdesivir, sofosbuvir and bemnifosbuvir.
-
NewsSeasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada
An interim analysis estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, offering protection beyond the vaccine’s target strain.
-
NewsScientists use ultrasound to destroy influenza A and COVID-19 viruses without damaging human cells
Researchers have discovered that high-frequency ultrasound waves similar to those used in medical exams can eliminate viruses such as SARS-CoV-2 and H1N1 without damaging human cells. Acoustic resonance causes structural changes in viral particles until they rupture and become inactivated.
-
NewsResearchers flip the CRISPR script to develop world’s first DNA-guided gene editing tool for precise infectious disease diagnosis
A research team has successfully developed the world’s first DNA-guided CRISPR-Cas system capable of programmable RNA targeting and cleavage. This breakthrough overturns the conventional CRISPR paradigm, which uses RNA as a guide to target DNA.
-
NewsWhy feeling sick may be important for surviving infection
In a new perspective, scientists propose a different way of thinking about sickness symptoms: what if these behaviors are part of an integrated immune strategy that operates across scales — from individual cells to tissues and organs, to the whole organism — and helps promote survival?
-
NewsStudy confirms effectiveness of medicinal plant against SARS-CoV-2 virus
A study has revealed that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree endemic to Brazil primarily found in the Atlantic Forest, have a multi-targeted effect against SARS-CoV-2, the virus that causes COVID-19.
-
NewsNew study shows antibodies need a strong core — not just grip — to fight SARS-CoV-2
Researchers used advanced computer simulations to investigate how antibody–virus complexes respond to mechanical forces across multiple SARS-CoV-2 variants, including the original 2019 strain and Omicron subvariants BA.4 and JN.1.
-
NewsThe handbook that can prepare countries for the next pandemic
A new handbook has been published to pave the way for better decision-making and greater preparedness for the next pandemic. It provides practical guidance on how mathematical models can be used to inform decision-making, and how the results can be communicated in times of crisis.
-
NewsCOVID-19 and severe heart attack increase mortality by 25% after one year, more than double pre-pandemic rates
Findings from the North American COVID-19 Myocardial Infarction (NACMI) registry demonstrate significantly higher one-year mortality rates in patients with COVID-19 and ST-elevation myocardial infarction (STEMI) compared to patients with STEMI alone.
-
NewsSARS-CoV-2 does not persist in the placenta after maternal recovery from COVID-19
A new study finds that the virus that causes COVID-19 does not linger in placental tissue weeks to months after a pregnant woman recovers from infection - offering important reassurance for clinicians and patients alike.
-
NewsCOVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.